Reaktionsgleichung
[NH2:1][C:2]1[CH:7]=[C:6]([CH3:8])[CH:5]=[CH:4][C:3]=1[NH:9][CH2:10][C@H:11]1[O:16][CH2:15][CH2:14][N:13]([C:17]([O:19][C:20]([CH3:23])([CH3:22])[CH3:21])=[O:18])[CH2:12]1.[F:24][C:25]1[CH:26]=[C:27]([CH:31]=[C:32]([F:36])[C:33]=1[CH:34]=O)[C:28]([OH:30])=[O:29].C(O)(=O)C>CO>[C:20]([O:19][C:17]([N:13]1[CH2:14][CH2:15][O:16][C@H:11]([CH2:10][N:9]2[C:3]3[CH:4]=[CH:5][C:6]([CH3:8])=[CH:7][C:2]=3[N:1]=[C:34]2[C:33]2[C:32]([F:36])=[CH:31][C:27]([C:28]([OH:30])=[O:29])=[CH:26][C:25]=2[F:24])[CH2:12]1)=[O:18])([CH3:23])([CH3:22])[CH3:21]Komponenten
Edukt 3
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
A mixture of (R)-tert-butyl 2-((2-amino-4-methylphenylamino)methyl)morpholine-4-carboxylate (600 mg, 1.87 mmol), 3,5-difluoro-4-formylbenzoic acid (347 mg, 1.87 mmol) and acetic acid (0.534 ml, 9.33 mmol) in methanol (15.0 ml) was stirred for 1.5 hr at room temperature. The mixture was then concentrated under reduced pressure, and the residue was purified by silica gel flash chromatography, eluting with mixtures of EtOAc and heptane, to afford (R)-4-(1-((4-(tert-butoxycarbonyl)morpholin-2-yl)methyl)-5-methyl-1H-benzo[d]imidazol-2-yl)-3,5-difluorobenzoic acid (750 mg, 82%) as an oil. The oil was analyzed on analytical HPLC MS using the high pH gradient method (mobile phase: 5-95% B; A: H2O with 10 mM NH4CO3 and 0.375% NH4OH v/v; B: CH3CN; 2.25 min run; X-Bridge C18; column size: 2.1×30 mm; particle size: 5 μm). MS m/z 488.4 [M+H]+ (ESI), Rt 1.56 min.
Aufarbeitung
- concentrationThe mixture was then concentrated under reduced pressure
- customthe residue was purified by silica gel flash chromatography
- washeluting with mixtures of EtOAc and heptane
Quellen und Nachweise
- ORD-Eintrag
- ord-36aa6bd91acc4a919a71b1846cced277
- Quelldatensatz
- uspto-grants-2013_09
- Patentnummer
- US08530467B2
Verknüpfte Notizen
Wird geladen…